Johnson & Johnson (JNJ)

JNJ on New York Consolidated

107.21USD
26 Nov 2014
Price Change (% chg)

$0.51 (+0.48%)
Prev Close
$106.70
Open
$106.77
Day's High
$107.25
Day's Low
$106.60
Volume
5,503,702
Avg. Vol
7,685,089
52-wk High
$109.49
52-wk Low
$86.09

JNJ

Chart for JNJ

About

Johnson & Johnson is a holding company engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The business of Johnson & Johnson is conducted by more than 275 operating companies located in 60 countries, including the United States, which sell products in virtually all... (more)

Overall

Beta: 0.56
Market Cap (Mil.): $300,092.59
Shares Outstanding (Mil.): 2,799.11
Dividend: 0.70
Yield (%): 2.61

Financials

  JNJ Industry Sector
P/E (TTM): 17.75 37.83 38.74
EPS (TTM): 6.04 -- --
ROI: 16.48 17.93 17.27
ROE: 23.66 18.73 18.18
Search Stocks

BRIEF-IP Group says Johnson & Johnson Innovation and Janssen partnership worth up to 176 mln stg

* Collaboration worth up to 176 mln stg with Johnson & Johnson Innovation and Janssen Source text for Eikon: Further company coverage: (Bangalore Newsroom +44 207 542 1810)

2:39am EST

Stryker weighing bid for Smith & Nephew: Bloomberg

LONDON - U.S. medical device maker Stryker Corp is examining a bid for Britain's Smith & Nephew Plc as a regulatory restriction barring an offer comes to an end, Bloomberg reported on Monday, citing unnamed sources.

24 Nov 2014

RPT-J&J seeks over $5 bln in damages from Boston Scientific at trial

NEW YORK, Nov 19 - Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp , Johnson & Johnson finally has a chance for payback at a multibillion-dollar trial set to begin on Thursday.

19 Nov 2014

BRIEF-Raisio acquired Benecol business from affiliates of Johnson & Johnson

* Has acquired Benecol business from affiliates of Johnson & Johnson

19 Nov 2014

J&J seeks over $5 billion in damages from Boston Scientific at trial

NEW YORK - Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp, Johnson & Johnson finally has a chance for payback at a multibillion-dollar trial set to begin on Thursday.

19 Nov 2014

J&J seeks over $5 bln in damages from Boston Scientific at trial

NEW YORK, Nov 19 - Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp , Johnson & Johnson finally has a chance for payback at a multibillion-dollar trial set to begin on Thursday.

19 Nov 2014

US STOCKS-Wall St flat after retail sales, UMich data

* Indexes: Dow off 0.01 pct, S&P up 0.05 pct, Nasdaq up 0.07 pct (Adds UMich data, Virgin America IPO)

14 Nov 2014

US STOCKS-Wall St opens flat after retail sales, UMich data on tap

* Indexes: Dow off 0.04 pct, S&P flat, Nasdaq off 0.11 pct (Updates to market open)

14 Nov 2014

US STOCKS-Wall St to open flat after retail sales, UMich data due

* Futures up: Dow 7 pts, S&P 0.5 pt, Nasdaq 0.75 pt (Adds data, updates prices)

14 Nov 2014

US STOCKS-Futures flat ahead of retail sales, UMich data

* Futures up: Dow 11 pts, S&P 1.5 pt, Nasdaq 2.75 pts (Adds premarket actives)

14 Nov 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks